Optimized Ki-67 staining in murine cells: a tool to determine cell proliferation.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 02 01 2019
accepted: 02 05 2019
pubmed: 17 5 2019
medline: 15 2 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

The reliable analysis of the cell cycle status has become increasingly relevant for scientific and clinical work, especially for the determination of tumor cell growth. One established method to characterize the proliferation activity of cells is the analysis of the Ki-67 protein. Ki-67 is expressed in the nucleus during the whole cell cycle except for the G0 phase. Several different protocols exist for the examination of the Ki-67 protein in tissue and cell culture, but most of them are defined for human cells. For the analysis of the Ki-67 protein in murine tissue and cell culture there is a variety of protocols existing which recommend different fixation and permeabilization reagents or special kits. In this study, we established a reliable protocol for Ki-67 staining in murine cells and tissue based on PFA fixation, which can be used not only for flow cytometry but also for immunofluorescence microscopy analysis. We tested our protocol successfully with three different Ki-67 anti-mouse antibodies in cell culture, regenerating liver tissue and mouse melanoma tumor to demonstrate the general applicability.

Identifiants

pubmed: 31093875
doi: 10.1007/s11033-019-04851-2
pii: 10.1007/s11033-019-04851-2
doi:

Substances chimiques

Ki-67 Antigen 0
Mki67 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4631-4643

Subventions

Organisme : Bonfor (DE)
ID : eAntrag 2014-1-22
Organisme : Bonfor (DE)
ID : PSP: O-117.0055

Références

Exp Cell Res. 2000 Jun 15;257(2):231-7
pubmed: 10837136
Methods Cell Biol. 2001;63:399-418
pubmed: 11060851
Curr Issues Mol Biol. 2001 Jul;3(3):67-70
pubmed: 11488413
Cytometry. 1992;13(2):204-8
pubmed: 1547670
Biotech Histochem. 1991;66(6):297-302
pubmed: 1725854
Nat Protoc. 2006;1(3):1458-61
pubmed: 17406435
Br J Cancer. 2007 May 21;96(10):1504-13
pubmed: 17453008
Nat Protoc. 2008;3(7):1167-70
pubmed: 18600221
Exp Cell Res. 1990 Mar;187(1):111-8
pubmed: 1967582
J Histotechnol. 2009 Mar 1;32(1):27-31
pubmed: 20160920
J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64
pubmed: 21960707
PLoS One. 2013 Jul 30;8(7):e68425
pubmed: 23935867
Stain Technol. 1985 Jan;60(1):7-11
pubmed: 2579484
PLoS One. 2015 Jul 15;10(7):e0119565
pubmed: 26177501
Int J Clin Exp Med. 2015 Jul 15;8(7):10235-47
pubmed: 26379815
Sci Rep. 2017 Mar 13;7:44281
pubmed: 28287186
Oncotarget. 2017 Jul 21;8(33):55298-55307
pubmed: 28903420
Virchows Arch. 2018 Mar;472(3):341-349
pubmed: 29134440
World J Hepatol. 2018 Jan 27;10(1):8-21
pubmed: 29399274
J Immunol Methods. 1986 Jun 10;90(1):65-70
pubmed: 3711671
J Immunol. 1984 Oct;133(4):1710-5
pubmed: 6206131
Int J Cancer. 1998 Aug 12;77(4):640-4
pubmed: 9679770

Auteurs

C Graefe (C)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

L Eichhorn (L)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

P Wurst (P)

Flow Cytometry Core Facility, Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.

J Kleiner (J)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

A Heine (A)

Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany.

I Panetas (I)

Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.

Z Abdulla (Z)

Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.

A Hoeft (A)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

S Frede (S)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

C Kurts (C)

Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.

E Endl (E)

Koordinationsstelle Research Infrastructure, University Hospital Bonn, Bonn, Germany.

C K Weisheit (CK)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany. Christina.Weisheit@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH